chr12-53501448-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_134323.2(TARBP2):c.40T>A(p.Cys14Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,569,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_134323.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000283 AC: 5AN: 176616Hom.: 0 AF XY: 0.0000318 AC XY: 3AN XY: 94264
GnomAD4 exome AF: 0.0000134 AC: 19AN: 1416924Hom.: 0 Cov.: 31 AF XY: 0.0000114 AC XY: 8AN XY: 700542
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2024 | The c.40T>A (p.C14S) alteration is located in exon 1 (coding exon 1) of the TARBP2 gene. This alteration results from a T to A substitution at nucleotide position 40, causing the cysteine (C) at amino acid position 14 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at